CORRECTION TO BASIC AND CLINICAL RESEARCH ON RETT SYNDROME AND MECP2 
PROGRAM ANNOUNCEMENT (PA-03-097)

RELEASE DATE:  April 22, 2003
 
NOTICE:  NOT-NS-03-014

National Institute of Neurological Disorders and Stroke (NINDS)
 (http://www.ninds.nih.gov)
National Institute of Child Health and Human Development (NICHD)
 (http://www.nichd.nih.gov)  

This is a change to the Program Announcement "Basic and Clinical
Research on Rett Syndrome and MeCP2".  In the SUBMITTING AN APPLICATION 
section, the following text has been inserted after the second 
paragraph:

SUPPLEMENTAL INSTRUCTIONS:  All instructions for the PHS 398 (rev. 
5/2001) must be followed, with these exceptions:

o   Research Plan

For R21 applications only, items a   d of the Research Plan (Specific 
Aims, Background and Significance, Preliminary Studies, and Research 
Design and Methods) may not exceed a total of 15 pages.  No preliminary 
data is required for R21 proposals, but may be included if it is 
available.  Please note that a Progress Report is not needed for R21 
awards; competing continuation applications for an 
exploratory/developmental grant will not be accepted.

Appendix.  Use the instructions for the appendix detailed in the PHS 
398 except that for R21 applications, no more than 5 manuscripts, 
previously accepted for publication, may be included.

INQUIRIES

Robert Finkelstein, Ph.D.
Neurogenetics Cluster
NINDS
6001 Executive Boulevard, Room 2143
Bethesda, MD 20892-9527
Telephone:  (301) 496-5745
FAX:  (301)  402-1501
Email:  [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®